Puma Biotechnology, Inc. (PBYI) vs Sight Sciences, Inc. (SGHT)

A side-by-side comparison of Puma Biotechnology, Inc. and Sight Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PBYI vs SGHT

growth of $100 · dividends reinvested · last 5y
PBYI +18.1% (+3.4%/yr)SGHT -73.4% (-23.3%/yr)PBYI compounded faster over this window
050100Start $10020222023202420252026$118$27
PBYI SGHT

PBYI vs SGHT: by the numbers

  • •PBYI is the larger company ($486M vs $468M market cap).
  • •PBYI is profitable (11.55% net margin) while SGHT runs a net loss (-35.69%).
  • •SGHT grew revenue faster over the past five years (16.53% vs 0.29% CAGR).

Metrics side by side

Valuation

MetricPBYISGHT
P/E ratio18.51N/A
Forward P/E25.15N/A
P/S ratio2.105.62
P/B ratio3.518.86
EV / EBITDA10.47N/A
FCF yield8.45%N/A

Profitability

MetricPBYISGHT
Gross margin74.83%87.96%
Operating margin13.16%-47.95%
Net margin11.55%-35.69%
ROE19.28%-56.26%
ROIC18.26%-29.50%

Growth (annualized)

MetricPBYISGHT
Revenue CAGR (5Y)0.29%16.53%
FCF CAGR (5Y)90.51%N/A
Total return CAGR (5Y)9.26%-18.69%

Frequently asked

Which has grown faster, PBYI or SGHT?
Over the past five years, SGHT grew revenue faster — PBYI at a 0.29% CAGR versus SGHT at 16.53%.
Is PBYI or SGHT more profitable?
PBYI runs the higher net margin — PBYI at 11.55% versus SGHT at -35.69%.
How have PBYI and SGHT total returns compared?
Over the past 5 years, PBYI delivered 9.26% and SGHT delivered -18.69% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.